• Perspective and Pathogenesis
• 23 min
  1. Expanding frontiers of cerebrovascular disease

  • Prof. Vladimir Hachinski
• 32 min
  2. Basic anatomy, physiology and pathophysiology of the cerebral circulation for the physician

  • Prof. Jean-Claude Baron
• 43 min
  3. Pathophysiology of cerebral ischemia

  • Prof. Wolf-Dieter Heiss
• 20 min
  4. Intracerebral hemorrhages: causes and clinical findings

  • Prof. Louis Caplan
• 40 min
  5. Subarachnoid hemorrhage (SAH)

  • Prof. R. Loch Macdonald
• Diagnosis
• 32 min
  6. Clinical diagnosis of stroke and subtypes

  • Prof. Louis Caplan
• 30 min
  7. The investigation of stroke

  • Dr. Bart Demaerschalk
• Treatment
• 35 min
  8. Acute therapy of stroke and reperfusion treatments

  • Prof. Brian Silver
• 39 min
  9. Subarachnoid hemorrhage diagnosis and management

  • Prof. Gary K. Steinberg
• 26 min
  10. Stroke-induced heart injury

  • Dr. Luciano A. Sposato
• Rehabilitation
• 37 min
  11. Stroke rehabilitation: principles of stroke

  • Prof. Robert Teasell
• 27 min
  12. Stroke rehabilitation: therapies and treatments

  • Prof. Robert Teasell
• Prevention
• 23 min
  13. Lifestyle and nutrition in stroke prevention

  • Prof. J. David Spence
• 40 min
  14. Prevention: carotid endarterectomy, angioplasty, and stenting

  • Prof. Brian Hoh
• Special Topics
• 54 min
  15. Pediatric stroke: cerebrovascular injury in the developing brain

  • Prof. Adam Kirton
• 43 min
  16. Stroke in women: epidemiology, risk and prevention

  • Prof. Cheryl Bushnell
• 25 min
  17. Transient ischemic attack and cognition

  • Dr. Jennifer Mandzia
• 31 min
  18. Vascular cognitive impairment

  • Prof. Eric E. Smith
• 34 min
  19. Atrial fibrillation, anticoagulation and vitamins for homocysteine

  • Prof. J. David Spence
• 41 min
  20. Stroke in the young adult

  • Prof. Jeffrey Saver
• 16 min
  21. Stroke in the young

  • Dr. Gyan Kumar
• 23 min
  22. Convergence and joint prevention of stroke and dementia

  • Prof. Vladimir Hachinski
• Archived Lectures *These may not cover the latest advances in the field
• 55 min
  23. Vascular cognitive impairment

  • Dr. John Bowler
• 32 min
  24. Pediatric stroke

  • Dr. Gabrielle deVeber
• 36 min
  25. The deteriorating stroke

  • Prof. Werner Hacke
• 27 min
  26. General management

  • Prof. Bo Norrving
• 35 min
  27. The treatment of stroke: specific management - thrombolysis plus

  • Prof. Nils Wahlgren
• 42 min
  28. Rehabilitation: the chronic phase

  • Prof. Lalit Kalra
• 61 min
  29. Prevention: management of risk and protective factors

  • Prof. Graeme Hankey
• 30 min
  30. Medical therapy for secondary prevention of ischemic stroke

  • Prof. Larry Goldstein
• 34 min
  31. Subarachnoid haemorrhage

  • Prof. Jan van Gijn
• 35 min
  32. Controversies in stroke

  • Prof. Stephen Davies
  • Prof. Geoffrey Donnan
• 35 min
  33. Medical and surgical stroke

  • Prof. Carlos Kase
• 35 min
  34. The urgency of stroke prevention after TIA

  • Prof. S. Claiborne Johnston
• 54 min
  35. Carotid endarterectomy, angioplasty and stenting

  • Prof. Martin Brown
• 42 min
  36. The clinical diagnosis of stroke and stroke subtypes

  • Prof. Louis Caplan

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Ischemic stroke: cumulative recurrence rates
3. Reducing recurrent stroke risk: lifestyle changes
4. Secondary prevention
5. Platelet antiaggregants
6. Aspirin for TIA and stroke
7. Clopidogrel - CAPRIE trial
8. CAPRIE trial: primary analysis
9. CAPRIE trial: outcome by disease strata
10. MATCH trial: study design
11. MATCH trial: results
12. CHARISMA trial
13. CHARISMA trial: results
14. Aspirin-sustained release dipyridamole (ESPS-2)
15. ESPRIT trial
16. ESPRIT trial: results
17. Secondary prevention: anticoagulants
18. Atrial fibrillation: warfarin vs. antiplatelet drugs
19. Atrial fibrillation: stroke risk stratification
20. Warfarin aspirin recurrent stroke study (WARSS)
21. WARSS trial: results
22. WASID trial
23. WASID trial: results
24. Secondary prevention: blood pressure
25. Antihypertensives- secondary prevention (UK-TIA)
26. BP treatment and stroke risk
27. PROGRESS trial
28. PROGRESS trial: results
29. Secondary prevention: lipid lowering
30. Statins for prevention of CVD and stroke
31. Heart protection study
32. HPS results: patients with vs. without prior stroke
33. SPARCL: study design
34. SPARCL results: primary endpoint
35. SPARCL results: secondary endpoints
36. SPARCL: NNT to prevent one event over 5 years
37. Safety
38. Post-hoc analyses: cerebrovascular endpoints
39. Post-hoc analysis: ischemic \ hemorrhagic stroke
40. Multivariable Cox regression model (1)
41. Multivariable Cox regression model (2)
42. Outcome by entry event: fatal or non-fatal stroke
43. Summary

Topics Covered

• Risk of recurrent stroke
• Lifestyle modification
• Platelet antiaggregant therapy; aspirin, clopidogrel, aspirin plus sustained-release dypiridamole
• Antihypertensive therapy
• Lipid lowering therapy

Links

Series:

• Cerebrovascular Disease

Categories:

• Clinical Practice
• Neuroscience

Therapeutic Areas:

• Neurology

Talk Citation

Publication History

• Published on October 27, 2008
• Archived on December 10, 2018

Financial Disclosures

• Prof. Larry Goldstein has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.